Jubilant Ingrevia Limited company name will engage with investors and analysts during the Equirus Annual India Conference 2026, scheduled for August 13 and 14, 2026, in Mumbai. The company disclosed the participation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirming that discussions will be based on generally available information without any Unpublished Price Sensitive Information.

The event involves one-on-one meetings between the company's management team and market participants. These sessions provide a platform for stakeholders to discuss the company’s operational performance and strategic outlook directly with leadership.

Event Details

The schedule is subject to change due to exigencies, as noted in the filing. Deepanjali Gulati, Company Secretary & Compliance Officer, signed the disclosure submitted to both BSE Limited and the National Stock Exchange of India Limited.

What This Means for Investors

The upcoming conference offers investors an opportunity to gain insights into Jubilant Ingrevia’s business trajectory through direct interaction with management. Such events are critical for maintaining transparency and aligning investor expectations with corporate strategy, particularly in the specialty chemicals sector where operational nuances drive valuation metrics.

Jubilant Ingrevia management will participate in the Nuvama India Conference 2026 in Singapore on August 11 and August 12, 2026. The company announced that its executives will engage in in-person, one-on-one meetings with investors and analysts during the event. This engagement aims to provide market participants with insights into the company’s performance and outlook using generally available information. The schedule is subject to change due to exigencies.

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Jubilant Ingrevia Limited filed the intimation with both the Bombay Stock Exchange and the National Stock Exchange of India Limited. The company emphasized that the discussions will not involve any Unpublished Price Sensitive Information (UPSI).

Event Details

The conference serves as a platform for listed companies to interact directly with institutional and retail investors. Such events are standard practice for maintaining transparency and keeping stakeholders informed about corporate developments. The management team will address queries related to the company’s operational and financial standing based on public disclosures.

Compliance and Governance

Deepanjali Gulati, Company Secretary and Compliance Officer of Jubilant Ingrevia Limited, signed the disclosure. The filing confirms adherence to regulatory requirements for investor relations activities. The company noted that the schedule may undergo changes due to exigencies, advising investors to monitor official communications for any updates.

This participation underscores the company’s commitment to regular investor communication. By engaging in one-on-one sessions, Jubilant Ingrevia allows for detailed discussions tailored to specific investor interests. The event takes place in Singapore, a key hub for Asian equity research and investment conferences.